SubHero Banner
Text

September 2022

Core topics in this month’s edition include:

  • Pradaxa (dabigatran etexilate) – first time generic
  • Skysona (elivaldogene autotemcel) – new orphan drug approval
  • Tresiba (insulin degludec) – new authorized brand alternative
  • Lecanemab – drug news update

Download PDF

Text